COST Action EU-METAHEART

EUropean network to tackle METAbolic alterations in HEART failure. Uniting scientists & clinicians to share skills & resources & educate next gen of researchers

[COST Action EU-METAHEART @EU_METAHEART]

Special thanks to the team of @NatRevCardiol, in particular Dr. Gregory Lim!

[COST Action EU-METAHEART @EU_METAHEART]

📢Focus issue of articles on the theme of metabolic alterations in heart failure to mark the start of the @Soc_HrtVasMetab meeting in Bordeaux⤵️

[Christoph Maack @ChristophMaack]

Our @COSTprogramme @EU_METAHEART CA22169 compiled a FOCUS ISSUE on METABOLIC ALTERATIONS in #heartfailure @NatRevCardiol. Read the editorial➡️https://t.co/zDbjIUlD2V & 4 Reviews outlined in thread⬇️@escardio @Soc_HrtVasMetab @AHAScience @DGKardio @dzhk_germany @ISHR_ES @ISHR_NAS

[Christoph Maack @ChristophMaack]

All 4 reviews are OPEN ACCESS for 1 month at https://t.co/lywim0B5Ef. Special thanks to the team of @NatRevCardiol, in particular Dr. Gregory Lim! Please also visit our website https://t.co/EyBc7ptmjx & become member at https://t.co/zwhIT7druI. @sfb1525 @Uni_WUE @DZHI_Wuerzburg

[Christoph Maack @ChristophMaack]

Finally, in review #4 @dunjaaks @simon_sedej @PaillardMel @KatrinStreckf @EdoardoBertero @JeremyFauconni1 et al discuss how the imbalance between mechanical load and mitochondrial ATP supply induces a redox mismatch that drives #heartfailure progression. https://t.co/O2EEDeHlEW

[Christoph Maack @ChristophMaack]

In review #3, @G_Vilahur @GhigoAlessandra et al. discuss how the interplay between #inflammation & #metabolism drives #heartfailure progression across etiologies & along the EF spectrum. In loving memory of Ioanna Andreadou https://t.co/DISyMk9Xqx.
https://t.co/4xaMORBIrb

[Christoph Maack @ChristophMaack]

In article #2, @liberale_luca @PKleinbongard et al. review the central role of coronary &systemic vascular dysfunction in #heartfailure (pEF&rEF), providing a mechanistic framework for therapies targeting the vasculature in different HF phenotypes. https://t.co/SCLmAYE6nk

[Christoph Maack @ChristophMaack]

In review #1, Mathias Mericskay et al. discuss dysregulated substrate & intermediary metabolism and its role for post-translational modifications in #heartfailure (HFpEF&rEF). W/contr by @gabrieleschiat1 @Heatherlab_ox @BertrandLuc_ky @AnjaKarlstaedt
https://t.co/BrcvVA9UzT

[COST Action EU-METAHEART @EU_METAHEART]

📢📢📢3rd meeting of the management committee (MC3) of our @EU_METAHEART COST Action on March 19 and 20, 2025 ➡️➡️➡️ please join online
👍Program and how to join online: https://t.co/yMOsobgTJM

[COST Action EU-METAHEART @EU_METAHEART]

📣📣📣A comprehensive overview on the multifaceted mechanisms driving cardiac amyloidosis led by @EU_METAHEART Core members
@liberale_luca @ChristophMaack @PKleinbongard
⏩https://t.co/1VCBp4eQsL

[COST Action EU-METAHEART @EU_METAHEART]

📢New Research Highlight from @EU_METAHEART consortium
“Empagliflozin in Acute Myocardial Infarction Reduces No-Reflow and Preserves Cardiac Function by Preventing Endothelial Damage”
by Panagiota-Efstathia Nicolau, Ioanna Andreadou
& collaborators⤵️
https://t.co/jYFEua9Ukg

[COST Action EU-METAHEART @EU_METAHEART]

🔊🔊🔊Call for Short-term scientific mission (STSM) open from Monday, November 25th until December 9th, 2024
🎓You are a Young Research Innovator? You want to visit another lab from @EU_METAHEART?
📝Apply for a grant up to 2k€
More info: https://t.co/LoLw1paDwR

[COST Action EU-METAHEART @EU_METAHEART]

📢📢📢SAVE THE DATE!!!
WG2 webinar on December 10th 2024 – 5PM CET
on microvascular dysfunction in Takotsubo & HF, & sex-specific differences
To join:
Zoom meeting-ID: 912 1197 3978
Password: 991198
more info⤵️⤵️⤵️⤵️

[COST Action EU-METAHEART @EU_METAHEART]

The Medical University of Graz (Austria) is opening a position of Tenure Track Professor of Sex and Gender-dependent Mechanisms in the Pathophysiology of Cardio-metabolic Disease
Application via their online job portal
https://t.co/TBX6X6lCs3
Application deadline: 7 November 2024

[COST Action EU-METAHEART @EU_METAHEART]

⚠️⚠️📢📢IMPORTANT NEWS!!!
our Website is now ON!!! Please take a look⤵️

EU-METAHEART | COST Action CA22169 – EUropean network to tackle METAbolic alterations in HEART failure (https://t.co/o5q8yos9mu)

to find out news, job opportunities & more💡🔍

[COST Action EU-METAHEART @EU_METAHEART]

📃📣 📣📣September news!
➡️Great success for our 1st Training School in Wurzburg on @OroborosI, Seahorse & @IonOptix with 18 students & postdocs
➡️ International conference with 4 awardees for their great presentation: Angeliki Dajou, Hualin Fan, Matus Miklovic & David Weissman

[COST Action EU-METAHEART @EU_METAHEART]

Lisa @Heatherlab_ox giving a nice overview on posttranslational modifications by metabolic intermediates in diabetes and other CV diseases @EU_METAHEART meeting. Much more in metabolism than just ATP! @gabrieleschiat1 @ISHR_ES @BasicResCardiol

[COST Action EU-METAHEART @EU_METAHEART]

@COSTprogramme EU-METAHEART is a EUropean network to tackle METAbolic alterations in #heartfailure. Follow us here &learn about our mission &join at https://t.co/NHunndfNCD. @DGK_org @escardio @dzhk_germany @CVR_TomaszGuzik @NatRevCardiol @NatMetabolism @Cell_Metabolism @ISHR_ES